Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Cash from Investing Activities (2020 - 2024)

Celularity (CELU) has disclosed Cash from Investing Activities for 5 consecutive years, with -$1.6 million as the latest value for Q4 2024.

  • On a quarterly basis, Cash from Investing Activities fell 174.31% to -$1.6 million in Q4 2024 year-over-year; TTM through Dec 2024 was $514000.0, a 112.7% increase, with the full-year FY2024 number at $514000.0, up 112.7% from a year prior.
  • Cash from Investing Activities was -$1.6 million for Q4 2024 at Celularity, down from $2.1 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $2.1 million in Q2 2024 to a low of -$9.4 million in Q4 2020.
  • A 5-year average of -$1.4 million and a median of -$1.1 million in 2021 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: tumbled 1175.64% in 2021, then skyrocketed 7016.13% in 2024.
  • Celularity's Cash from Investing Activities stood at -$9.4 million in 2020, then surged by 75.43% to -$2.3 million in 2021, then skyrocketed by 66.17% to -$779000.0 in 2022, then increased by 25.55% to -$580000.0 in 2023, then crashed by 174.31% to -$1.6 million in 2024.
  • Per Business Quant, the three most recent readings for CELU's Cash from Investing Activities are -$1.6 million (Q4 2024), $2.1 million (Q2 2024), and -$39000.0 (Q1 2024).